Form 10QSB - Optional form for quarterly and transition reports of small business issuers:
SEC Accession No. 0001144204-07-024513
Filing Date
2007-05-11
Accepted
2007-05-11 16:01:50
Documents
5
Period of Report
2007-03-31

Document Format Files

Seq Description Document Type Size
1 v073760_10qsb.htm 10QSB 273525
2 v073760_ex31-1.htm EX-31.1 11414
3 v073760_ex31-2.htm EX-31.2 11549
4 v073760_ex32-1.htm EX-32.1 6631
5 v073760_ex32-2.htm EX-32.2 7066
  Complete submission text file 0001144204-07-024513.txt   311688
Mailing Address C/O PARAMOUNT BIOCAPITAL INVESTMENTS LLC 787 SEVENTH AVENUE 48TH FLOOR NEW YORK NY 10019
Business Address C/O PARAMOUNT BIOCAPITAL INVESTMENTS LLC 787 SEVENTH AVENUE 48TH FLOOR NEW YORK NY 10019 (212)554-4300
BRISTOL BAY SCIENCES, INC. (Filer) CIK: 0001344292 (see all company filings)

EIN.: 203327183 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10QSB | Act: 34 | File No.: 000-51621 | Film No.: 07842380
SIC: 6770 Blank Checks